These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2124499)

  • 1. Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling.
    Mazurier C; Gaucher C; Jorieux S; Parquet-Gernez A; Goudemand M
    Br J Haematol; 1990 Nov; 76(3):372-9. PubMed ID: 2124499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.
    López-Fernández MF; Blanco-López MJ; Castiñeira MP; Batlle J
    Am J Hematol; 1992 May; 40(1):20-7. PubMed ID: 1566742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
    Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
    Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
    Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.
    Mazurier C; Dieval J; Jorieux S; Delobel J; Goudemand M
    Blood; 1990 Jan; 75(1):20-6. PubMed ID: 2104761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between VWF and FVIII in treating VWD.
    Miesbach W; Berntorp E
    Eur J Haematol; 2015 Nov; 95(5):449-54. PubMed ID: 25605439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization.
    Schneppenheim R; Lenk H; Obser T; Oldenburg J; Oyen F; Schneppenheim S; Schwaab R; Will K; Budde U
    Thromb Haemost; 2004 Jul; 92(1):36-41. PubMed ID: 15213842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.
    Lavergne JM; Piao Y; Ribba AS; Girma JP; Siguret V; Piétu G; Boyer-Neumann C; Schandelong A; Bahnak BR; Meyer D
    Thromb Haemost; 1993 Oct; 70(4):691-6. PubMed ID: 8115998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an automated screening assay for von Willebrand disease type 2N.
    Taylor SL; Bromidge E; Savidge GF; Alhaq A
    Clin Lab Haematol; 2002 Dec; 24(6):369-75. PubMed ID: 12452818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia A.
    Mazurier C; Parquet-Gernez A; Gaucher C; Lavergne JM; Goudemand J
    Br J Haematol; 2002 Nov; 119(2):390-2. PubMed ID: 12406074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
    Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
    Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.
    Terraube V; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jan; 16(1):3-13. PubMed ID: 19473409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB; Crane S
    Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010.
    Gringeri A; Ofosu FA; Grancha S; Oldenburg J; Ewing NP; Federici AB
    Haemophilia; 2012 May; 18(3):469-75. PubMed ID: 21943193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII.
    Rock G; Adamkiewicz T; Blanchette V; Poon A; Sparling C
    Br J Haematol; 1996 Jun; 93(3):684-7. PubMed ID: 8652394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.